{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:37:24Z","timestamp":1790095044770,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17H04009"],"award-info":[{"award-number":["JP17H04009"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K19401"],"award-info":[{"award-number":["JP18K19401"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H03404"],"award-info":[{"award-number":["JP20H03404"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K20718"],"award-info":[{"award-number":["JP21K20718"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bbrc.2022.01.058","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T11:15:54Z","timestamp":1642590954000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Vaccine using community-acquired respiratory distress syndrome toxin as an antigen against Mycoplasma pneumoniae in mice"],"prefix":"10.1016","volume":"594","author":[{"given":"Eisuke","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Tamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7265-9221","authenticated-orcid":false,"given":"Yasuo","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.01.058_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","article-title":"Mycoplasma pneumoniae and its role as a human pathogen","volume":"17","author":"Waites","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2022.01.058_bib2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond","volume":"30","author":"Waites","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2022.01.058_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2022.01.058_bib4","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1378\/chest.121.6.1782","article-title":"Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin","volume":"121","author":"Kraft","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.bbrc.2022.01.058_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2217\/fmb.11.18","article-title":"Mycoplasma pneumoniae: susceptibility and resistance to antibiotics","volume":"6","author":"Bebear","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.bbrc.2022.01.058_bib6","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.02060-12","article-title":"Surveillance of macrolide-resistant mycoplasma pneumoniae in Beijing, China, from 2008 to 2012","volume":"57","author":"Zhao","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2022.01.058_bib7","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1128\/IAI.00268-09","article-title":"Strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development","volume":"77","author":"Schurwanz","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2022.01.058_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1139\/w2012-041","article-title":"Protective immune responses in mice induced by intramuscular and intranasal immunization with a Mycoplasma pneumoniae P1C DNA vaccine","volume":"58","author":"Zhu","year":"2012","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.bbrc.2022.01.058_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.micpath.2013.07.004","article-title":"Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of Guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan","volume":"64","author":"Hausner","year":"2013","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bbrc.2022.01.058_bib10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fmicb.2016.00414","article-title":"Inflammation-inducing factors of mycoplasma pneumoniae","volume":"7","author":"Shimizu","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2022.01.058_bib11","article-title":"Role of the mycoplasma pneumoniae\/interleukin-8\/neutrophil Axis in the pathogenesis of pneumonia","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2022.01.058_bib12","article-title":"The clinical characteristics and predictors of refractory mycoplasma pneumoniae pneumonia in children","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2022.01.058_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01588-21","article-title":"Neutrophil-mediated lung injury both via TLR2-dependent production of IL-1alpha and IL-12 p40, and TLR2-independent CARDS toxin after mycoplasma pneumoniae infection in mice","volume":"9","author":"Tamiya","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbrc.2022.01.058_bib14","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1128\/IAI.73.5.2828-2834.2005","article-title":"Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae","volume":"73","author":"Kannan","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2022.01.058_bib15","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1073\/pnas.0510644103","article-title":"ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens","volume":"103","author":"Kannan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2022.01.058_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1164\/rccm.201001-0080OC","article-title":"Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains","volume":"182","author":"Techasaensiri","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbrc.2022.01.058_bib17","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/infdis\/jir557","article-title":"Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model","volume":"204","author":"Kannan","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.bbrc.2022.01.058_bib18","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1365-2958.2010.07092.x","article-title":"Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation","volume":"76","author":"Kannan","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbrc.2022.01.058_bib19","first-page":"5","article-title":"Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells","author":"Somarajan","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.bbrc.2022.01.058_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/616385db-f413-4f23-ba78-2fe626870e46","article-title":"Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin","volume":"4","author":"Hardy","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2022.01.058_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1165\/rcmb.2011-0135OC","article-title":"Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation","volume":"46","author":"Medina","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2022.01.058_bib22","first-page":"5","article-title":"ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity","author":"Bose","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.bbrc.2022.01.058_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1165\/rcmb.2017-0006OC","article-title":"The immunopathologic effects of mycoplasma pneumoniae and community-acquired respiratory distress syndrome toxin. A primate model","volume":"58","author":"Maselli","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2022.01.058_bib24","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1016\/j.vaccine.2020.05.074","article-title":"Vaccination using inactivated Mycoplasma pneumoniae induces detrimental infiltration of neutrophils after subsequent infection in mice","volume":"38","author":"Tamiya","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2022.01.058_bib25","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3389\/fimmu.2019.02274","article-title":"Enhancing immune response and heterosubtypic protection ability of inactivated H7N9 vaccine by using STING agonist as a mucosal adjuvant","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2022.01.058_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01180-21","article-title":"The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses","volume":"95","author":"Kawai","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2022.01.058_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01663-17","article-title":"Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin uses a novel KELED sequence for retrograde transport and subsequent cytotoxicity","volume":"9","author":"Ramasamy","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.bbrc.2022.01.058_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/intimm\/dxu063","article-title":"Challenges in mucosal vaccines for the control of infectious diseases","volume":"26","author":"Azegami","year":"2014","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbrc.2022.01.058_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","article-title":"Current prospects and future challenges for nasal vaccine delivery","volume":"13","author":"Yusuf","year":"2017","journal-title":"Hum. Vaccines Immunother."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2200078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2200078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:14:47Z","timestamp":1757765687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2200078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"alternative-id":["S0006291X2200078X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.01.058","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine using community-acquired respiratory distress syndrome toxin as an antigen against Mycoplasma pneumoniae in mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.01.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}